Endocrinology, Vol 124, 2791-2798, Copyright © 1989 by Endocrine Society

ARTICLES

The synergistic effects of His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 on growth hormone (GH)-releasing factor-stimulated GH release and intracellular adenosine 3',5'-monophosphate accumulation in rat primary pituitary cell culture

K Cheng, WW Chan, A Barreto Jr, EM Convey and RG Smith
Merck, Sharp, and Dohme Research Laboratories, Department of Growth Biochemistry and Physiology, Rahway, New Jersey 07065.

His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 (GHRP-6) stimulated GH release from rat primary pituitary cells in a time- and dose-dependent manner. Stimulation was observed after a 15-min, but not a 4-h, incubation. The concentrations of GHRP-6 required for half-maximal and maximal stimulation were 7 x 10(-9) and 10(-7) M, respectively. GH release induced by GHRP-6 was not affected by the addition of either naloxone or the GRF antagonist [N-Ac-Tyr1,D-Arg2]GRF-(1-29)-NH2. The latter inhibited GRF-stimulated GH release by shifting the dose-response curve to the right. His-D-Trp-D-Lys-Trp-D-Phe-Lys-NH2, an analog of GHRP-6, inhibited GH release stimulated by GHRP-6 without affecting that induced by GRF. When present together at maximal concentrations, GHRP-6 and GRF produced a synergistic effect on GH release. GHRP-6 had no effect on intracellular cAMP levels, whereas GRF increased intracellular cAMP concentrations by 3-fold. Combined treatment of pituitary cells with GRF and GHRP-6 resulted in a potentiation of the GRF-induced increase in cAMP levels. Basal GH release was reduced by 30% after pretreatment with GHRP-6 (10(-7) M) for 1 h. Pretreatment with GHRP-6 also decreased the subsequent response to GHRP-6, but not GRF. In contrast, pretreatment with GRF for 1 h had no effect on the subsequent action of GHRP-6 or GRF on GH release. The desensitization induced by GHRP-6 was completely reversed within 1 h after removal of the peptide. Results from this study indicate that GHRP-6 and GRF stimulated GH release from somatotrophs via different receptors and through discrete mechanisms.

This article has been cited by other articles:

				R. D. Kineman and R. M. Luque Evidence that Ghrelin Is as Potent as Growth Hormone (GH)-Releasing Hormone (GHRH) in Releasing GH from Primary Pituitary Cell Cultures of a Nonhuman Primate (Papio anubis), Acting through Intracellular Signaling Pathways Distinct from GHRH Endocrinology, September 1, 2007; 148(9): 4440 - 4449. [Abstract] [Full Text] [PDF]

				D. Kohno, M. Nakata, F. Maekawa, K. Fujiwara, Y. Maejima, M. Kuramochi, T. Shimazaki, H. Okano, T. Onaka, and T. Yada Leptin Suppresses Ghrelin-Induced Activation of Neuropeptide Y Neurons in the Arcuate Nucleus via Phosphatidylinositol 3-Kinase- and Phosphodiesterase 3-Mediated Pathway Endocrinology, May 1, 2007; 148(5): 2251 - 2263. [Abstract] [Full Text] [PDF]

				R. R. Kraemer and V. D. Castracane Exercise and Humoral Mediators of Peripheral Energy Balance: Ghrelin and Adiponectin Experimental Biology and Medicine, February 1, 2007; 232(2): 184 - 194. [Abstract] [Full Text] [PDF]

				D. Stevanovic, V. Milosevic, D. Nesic, V. Ajdzanovic, V. Starcevic, and W. B. Severs A BRIEF COMMUNICATION: Central Effects of Ghrelin on Serum Growth Hormone and Morphology of Pituitary Somatotropes in Rats. Experimental Biology and Medicine, November 1, 2006; 231(10): 1610 - 1615. [Abstract] [Full Text] [PDF]

				H. Jiang, L. Betancourt, and R. G. Smith Ghrelin Amplifies Dopamine Signaling by Cross Talk Involving Formation of Growth Hormone Secretagogue Receptor/Dopamine Receptor Subtype 1 Heterodimers Mol. Endocrinol., August 1, 2006; 20(8): 1772 - 1785. [Abstract] [Full Text] [PDF]

				K. J. Pulman, W. M. Fry, G. T. Cottrell, and A. V. Ferguson The Subfornical Organ: A Central Target for Circulating Feeding Signals J. Neurosci., February 15, 2006; 26(7): 2022 - 2030. [Abstract] [Full Text] [PDF]

				P. Zizzari, H. Halem, J. Taylor, J. Z. Dong, R. Datta, M. D. Culler, J. Epelbaum, and M. T. Bluet-Pajot Endogenous Ghrelin Regulates Episodic Growth Hormone (GH) Secretion by Amplifying GH Pulse Amplitude: Evidence from Antagonism of the GH Secretagogue-R1a Receptor Endocrinology, September 1, 2005; 146(9): 3836 - 3842. [Abstract] [Full Text] [PDF]

				R. G. Smith Development of Growth Hormone Secretagogues Endocr. Rev., May 1, 2005; 26(3): 346 - 360. [Abstract] [Full Text] [PDF]

				M. Kojima and K. Kangawa Ghrelin: Structure and Function Physiol Rev, April 1, 2005; 85(2): 495 - 522. [Abstract] [Full Text] [PDF]

				J. Kamegai, H. Tamura, T. Shimizu, S. Ishii, A. Tatsuguchi, H. Sugihara, S. Oikawa, and R. D. Kineman The Role of Pituitary Ghrelin in Growth Hormone (GH) Secretion: GH-Releasing Hormone-Dependent Regulation of Pituitary Ghrelin Gene Expression and Peptide Content Endocrinology, August 1, 2004; 145(8): 3731 - 3738. [Abstract] [Full Text] [PDF]

				A. J. van der Lely, M. Tschop, M. L. Heiman, and E. Ghigo Biological, Physiological, Pathophysiological, and Pharmacological Aspects of Ghrelin Endocr. Rev., June 1, 2004; 25(3): 426 - 457. [Abstract] [Full Text] [PDF]

				A Asakawa, A Inui, T Kaga, G Katsuura, M Fujimiya, M A Fujino, and M Kasuga Antagonism of ghrelin receptor reduces food intake and body weight gain in mice Gut, July 1, 2003; 52(7): 947 - 952. [Abstract] [Full Text]

				H. Hosoda, M. Kojima, and K. Kangawa Ghrelin and the Regulation of Food Intake and Energy Balance Mol. Interv., December 1, 2002; 2(8): 494 - 503. [Abstract] [Full Text]

				S. R. Cunha and K. E. Mayo Ghrelin and Growth Hormone (GH) Secretagogues Potentiate GH-Releasing Hormone (GHRH)-Induced Cyclic Adenosine 3',5'-Monophosphate Production in Cells Expressing Transfected GHRH and GH Secretagogue Receptors Endocrinology, December 1, 2002; 143(12): 4570 - 4582. [Abstract] [Full Text] [PDF]

				A. Garcia, C. V. Alvarez, R. G. Smith, and C. Dieguez Regulation of PIT-1 Expression By Ghrelin and GHRP-6 Through the GH Secretagogue Receptor Mol. Endocrinol., September 1, 2001; 15(9): 1484 - 1495. [Abstract] [Full Text] [PDF]

				A.-C. A. R. Pinto, M. R. D. Silva, M. R. Martins, E. Brunner, and A.-M. J. Lengyel Effects of Short-Term Glucocorticoid Deprivation on Growth Hormone (GH) Response to GH-Releasing Peptide-6: Studies in Normal Men and in Patients with Adrenal Insufficiency J. Clin. Endocrinol. Metab., April 1, 2000; 85(4): 1540 - 1544. [Abstract] [Full Text]

				M. Roumi, S. Marleau, P. du Souich, T. Maggi, R. Deghenghi, and H. Ong Kinetics and Disposition of Hexarelin, A Peptidic Growth Hormone Secretagogue, in Rats Drug Metab. Dispos., January 1, 2000; 28(1): 44 - 50. [Abstract] [Full Text]

				R. D. Kineman, J. Kamegai, and L. A. Frohman Growth Hormone (GH)-Releasing Hormone (GHRH) and the GH Secretagogue (GHS), L692,585, Differentially Modulate Rat Pituitary GHS Receptor and GHRH Receptor Messenger Ribonucleic Acid Levels Endocrinology, August 1, 1999; 140(8): 3581 - 3586. [Abstract] [Full Text]

				M. Korbonits, G. Kaltsas, L. A. Perry, P. Putignano, A. B. Grossman, G. M. Besser, and P. J. Trainer The Growth Hormone Secretagogue Hexarelin Stimulates the Hypothalamo-Pituitary-Adrenal Axis via Arginine Vasopressin J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2489 - 2495. [Abstract] [Full Text]

				E. E. Muller, V. Locatelli, and D. Cocchi Neuroendocrine Control of Growth Hormone Secretion Physiol Rev, April 1, 1999; 79(2): 511 - 607. [Abstract] [Full Text] [PDF]

				A. Giustina and J. D. Veldhuis Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human Endocr. Rev., December 1, 1998; 19(6): 717 - 797. [Abstract] [Full Text]

				M. M. Skinner, R. Nass, B. Lopes, E. R. Laws, and M. O. Thorner Growth Hormone Secretagogue Receptor Expression in Human Pituitary Tumors J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4314 - 4320. [Abstract] [Full Text]

				M. Maghnie, V. Spica-Russotto, M. Cappa, M. Autelli, C. Tinelli, P. Civolani, R. Deghenghi, F. Severi, and S. Loche The Growth Hormone Response to Hexarelin in Patients with Different Hypothalamic-Pituitary Abnormalities J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 3886 - 3889. [Abstract] [Full Text]

				K. Hanew, A. Utsumi, A. Tanaka, H. Ikeda, and Y. Yokogoshi Secretory Mechanisms of Growth Hormone (GH)-Releasing Peptide-, GH-Releasing Hormone-, and Thyrotropin-Releasing Hormone-Induced GH Release in Patients with Acromegaly J. Clin. Endocrinol. Metab., October 1, 1998; 83(10): 3578 - 3583. [Abstract] [Full Text]

				M. Korbonits, R. A. Jacobs, S. J. B. Aylwin, J. M. Burrin, P. L. M. Dahia, J. P. Monson, J. Honegger, R. Fahlbush, P. J. Trainer, S. L. Chew, et al. Expression of the Growth Hormone Secretagogue Receptor in Pituitary Adenomas and Other Neuroendocrine Tumors J. Clin. Endocrinol. Metab., October 1, 1998; 83(10): 3624 - 3630. [Abstract] [Full Text]

				N. Pandya, R. DeMott-Friberg, C. Y. Bowers, A. L. Barkan, and C. A. Jaffe Growth Hormone (GH)-Releasing Peptide-6 Requires Endogenous Hypothalamic GH-Releasing Hormone for Maximal GH Stimulation J. Clin. Endocrinol. Metab., April 1, 1998; 83(4): 1186 - 1189. [Abstract] [Full Text]

				I. Shimon, X. Yan, and S. Melmed Human Fetal Pituitary Expresses Functional Growth Hormone-Releasing Peptide Receptors J. Clin. Endocrinol. Metab., January 1, 1998; 83(1): 174 - 178. [Abstract] [Full Text]

				P. A. Bennett, G. B. Thomas, A. D. Howard, S. D. Feighner, L. H. T. Van der Ploeg, R. G. Smith, and I. C. A. F. Robinson Hypothalamic Growth Hormone Secretagogue-Receptor (GHS-R) Expression Is Regulated by Growth Hormone in the Rat Endocrinology, November 1, 1997; 138(11): 4552 - 4557. [Abstract] [Full Text] [PDF]

				R. G. Smith, L. H. T. Van der Ploeg, A. D. Howard, S. D. Feighner, K. Cheng, G. J. Hickey, M. J. Wyvratt Jr., M. H. Fisher, R. P. Nargund, and A. A. Patchett Peptidomimetic Regulation of Growth Hormone Secretion Endocr. Rev., October 1, 1997; 18(5): 621 - 645. [Abstract] [Full Text]

				K. K. McKee, O. C. Palyha, S. D. Feighner, D. L. Hreniuk, C. P. Tan, M. S. Phillips, R. G. Smith, L. H. T. Van der Ploeg, and A. D. Howard Molecular Analysis of Rat Pituitary and Hypothalamic Growth Hormone Secretagogue Receptors Mol. Endocrinol., April 1, 1997; 11(4): 415 - 423. [Abstract] [Full Text]

				G. B. Thomas, K. M. Fairhall, and I. C. A. F. Robinson Activation of the Hypothalamo-Pituitary-Adrenal Axis by the Growth Hormone (GH) Secretagogue, GH-Releasing Peptide-6, in Rats Endocrinology, April 1, 1997; 138(4): 1585 - 1591. [Abstract] [Full Text] [PDF]

				S. Loche, A. Colao, M. Cappa, J. Bellone, G. Aimaretti, G. Farello, A. Faedda, G. Lombardi, R. Deghenghi, and E. Ghigo The Growth Hormone Response to Hexarelin in Children: Reproducibility and Effect of Sex Steroids J. Clin. Endocrinol. Metab., March 1, 1997; 82(3): 861 - 864. [Abstract] [Full Text] [PDF]

				T. Wells, D. M. Flavell, S. E. Wells, D. F. Carmignac, and I. C. A. F. Robinson Effects of Growth Hormone Secretagogues in the Transgenic Growth-Retarded (Tgr) Rat Endocrinology, February 1, 1997; 138(2): 580 - 587. [Abstract] [Full Text] [PDF]

				S. L. Dickson and S. M. Luckman Induction of c-fos Messenger Ribonucleic Acid in Neuropeptide Y and Growth Hormone (GH)-Releasing Factor Neurons in the Rat Arcuate Nucleus Following Systemic Injection of the GH Secretagogue, GH-Releasing Peptide-6 Endocrinology, February 1, 1997; 138(2): 771 - 777. [Abstract] [Full Text] [PDF]

				R. Smith, K Cheng, W. Schoen, S. Pong, G Hickey, T Jacks, B Butler, W. Chan, L. Chaung, F Judith, et al. A nonpeptidyl growth hormone secretagogue Science, June 11, 1993; 260(5114): 1640 - 1643. [Abstract] [PDF]

				H. Kaiya, M. Kojima, H. Hosoda, A. Koda, K. Yamamoto, Y. Kitajima, M. Matsumoto, Y. Minamitake, S. Kikuyama, and K. Kangawa Bullfrog Ghrelin Is Modified by n-Octanoic Acid at Its Third Threonine Residue J. Biol. Chem., October 26, 2001; 276(44): 40441 - 40448. [Abstract] [Full Text] [PDF]